AlphAIAlphAI — Financial news for AI agents
investing.comNOV 21 min read$CE

Celanese earnings beat by $0.09, revenue fell short of estimates

Celanese (CE) reported Q3 EPS of $1.65, beating estimates by $0.09, but revenue of $2.56B missed expectations. The company forecasts FY 2026 EPS of $6.00-$6.25, matching analyst consensus. CE's stock is up 9.08% over 3 months and 29.36% over 12 months, with a 'good performance' financial health score according to InvestingPro.

Original reporting
investing.com
Published Nov 2, 2026, 9:22 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 2, 2026, 9:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$CE
Bullish
high confidence
Mentioned
$CE
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$CEBullishHigh
01

Why it matters

The earnings beat on EPS and raised FY guidance are likely to attract buying interest, though the revenue shortfall may temper enthusiasm.

02

Market read

First disclosure of Celanese's Q3 earnings and FY guidance, offering a fresh trading catalyst.

03

What to watch

Potential headwinds from raw material costs and macro slowdown are not reflected in the earnings beat.

Relevance 8/10Novelty 8/10Timing: after-hours today

Background

Celanese (NYSE: CE) is a specialty chemicals manufacturer. The article provides its Q3 earnings release and FY guidance.

Company-level read

Ticker impact

$CEBullishHigh confidence
Context

Celanese reported Q3 EPS of $1.65, beating estimates by $0.09 and provided FY 2026 EPS guidance of $6.00-$6.25.

Expected impact

potential upward pressure as investors price in the EPS beat and higher guidance

Evidence & confidence

The beat is the first public disclosure of the quarter's results; EPS surprise and guidance raise expectations.

Market effects

Sector

Chemicals sector may see modest uplift as a large peer reports earnings beat.

Regional

U.S. market participants may adjust exposure to specialty chemicals.

Global

Limited to investors tracking U.S. industrials.

Counterpoint

What could challenge this read

Revenue miss and modest EPS beat could signal underlying demand weakness, suggesting caution.

Key entities

  • Company
    Celanese

    Specialty chemicals producer reporting Q3 results.

Read at source← All news

StoryCelanese posts Q3 earnings beat and lifts full‑year cash‑flow and EPS outlook

Also covered by

3 outlets

Related articles

NOV 2
$CEMed

Celanese: Q3 Earnings Snapshot

Celanese Corporation (CE) reported Q3 earnings of $74M, or $1.65 per share adjusted, exceeding analyst expectations of $1.52. Revenue was $2.56B, slightly below forecasts. The company expects full-year earnings of $6 to $6.25 per share.

finance.yahoo.com1 min
NOV 2
$CEHighAI 8/10

Celanese beats profit estimates with strong cash generation

Celanese (NYSE:CE) reported Q3 adjusted EPS of $1.65, beating estimates, but revenue of $2.56B missed expectations. Net sales rose 6% YoY. The company raised its full-year 2026 adjusted EPS guidance to $6.00-$6.25 and increased its free cash flow outlook to $750M-$800M. Shares gained 1.9% in after-hours trading. Celanese also announced a $152M deal to sell part of its Nutrinova joint venture.

investing.com2 min
NOV 2
$CEHigh

Celanese Corporation Reports Third Quarter Earnings

Celanese Corp (CE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Celanese Corporation Reports Third Quarter Earnings; Exceeds Third Quarter Guidance and Raises Full Year Outlook Dallas, November 2, 2026: Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today reported third quarter 2026 U.S. GAAP

SEC EDGAR 8-K2 min
OCT 16
$CEMed

Celanese stock falls after raising LCP prices globally

Celanese Corporation (NYSE:CE) shares dropped 4.3% after hours on Friday after the company announced global price increases for its liquid crystal polymer (LCP) products. The increases, effective immediately, range from $0.45 to $3.50 per unit depending on the product and region. The company cited strong demand, rising costs, and supply chain disruptions as reasons for the price adjustments. Celanese reported 2025 net sales of $9.5 billion.

investing.com3 min
SEP 22
$CEHighAI 8/10

Why is Celanese stock rallying today?

Celanese (CE) shares rose 7.5% after announcing immediate price hikes for key products in multiple regions, seen as a catalyst for margin recovery. The move is part of broader restructuring efforts, including asset sales. The company maintained its 2026 EPS guidance. The rally is company-specific, not driven by broader market trends. CE operates as a major producer of acetic acid and vinyl acetate monomer.

investing.com2 min